Hierarchical Targeting Nanodrug with Holistic DNA Protection for Effective Treatment of Acute Kidney Injury
Advanced Science · 2025
DOI: 10.1002/advs.202411254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Qiaohui Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Antioxidants, Drug Delivery Systems, DNA. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research Project of Ningxia Hui Autonomous Region of China (Major Project), Key Research and Development Program of Hunan Province.
Abstract (Originalsprache)
Acute kidney injury (AKI) manifests a hallmark pathological feature of extensive and severe DNA damage in renal tubules, primarily induced by the excessive of toxic reactive oxygen species (ROS) from the mitochondrial electron transport chain. The kidney's complex intricate physiological architecture and the heterogeneous intracellular environment pose significant challenges for effective sequential and high‐resolution drug delivery—an urgent issue that remains unresolved. To address this, a hierarchical‐targeting antioxidant nanodrug has been developed with a folic acid moiety (HAND) designed for high‐resolution drug delivery in AKI treatment. For the first time, HAND enables sequential targeting from the kidney to the most severely damaged proximal tubular epithelial cells (PTECs), ultimately concentrating in the DNA‐rich mitochondria and nucleus. As a result, HAND effectively scavenges ROS in situ, protecting both mitochondria and nuclei along with their vital genetic material. This action restores mitochondrial function, mitigates DNA oxidation and fragmentation, reduces apoptosis, and inhibits cGAS/STING‐mediated sterile inflammation. Consequently, HAND demonstrates remarkable efficacy in safeguarding injured kidneys during AKI. Overall, this work pioneers a hierarchical, high‐resolution antioxidant strategy, providing innovative guidance for the development of AKI therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, China.
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, China.
- Hunan Provincial Key Laboratory of Cardiovascular Research, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, China.
- Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
- Department of Pancreatic Surgery, Xiangya Hospital, Central South University, Changsha, 410008, China.
- Department of General Surgery, Xiangya Hospital, Central South University, Changsha, 410008, China.
ORCID-Profile: Kelong Ai
Förderung
- National Natural Science Foundation of China
- Key Research Project of Ningxia Hui Autonomous Region of China (Major Project)
- Key Research and Development Program of Hunan Province
- Central South University Research Programme of Advanced Interdisciplinary Studies
- Project Program of National Clinical Research Center for Geriatric Disorders (Xiangya Hospital)
- Key Program of Ningxia Hui Autonomous Region Natural Science Foundation of China
Zitieren
APA
Chen, Q., Yang, Y., Ying, X., Huang, C., Chen, J., Wang, J., Wu, Z., Zeng, W., Miao, C., Shi, X., Nan, Y., Huang, Q., & Ai, K. (2025). Hierarchical Targeting Nanodrug with Holistic DNA Protection for Effective Treatment of Acute Kidney Injury. Advanced Science. https://doi.org/10.1002/advs.202411254
Vancouver
Chen Q, Yang Y, Ying X, Huang C, Chen J, Wang J, et al. Hierarchical Targeting Nanodrug with Holistic DNA Protection for Effective Treatment of Acute Kidney Injury. Advanced Science. 2025. doi:10.1002/advs.202411254
BibTeX
@article{Chen2025,
author = {Chen, Qiaohui and Yang, Yongqi and Ying, Xiaohong and Huang, Changkun and Chen, Jianlin and Wang, Jue and Wu, Ziyu and Zeng, Wan and Miao, Chenxi and Shi, Xiaojing and Nan, Yayun and Huang, Qiong and Ai, Kelong},
title = {Hierarchical Targeting Nanodrug with Holistic DNA Protection for Effective Treatment of Acute Kidney Injury},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202411254}
}
EUVIMED